Rahul P. Pol
Research Subjects
Research Interests
Rahul P. Pol has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Atul R. Chopade
Rajarambapu College of Pharmacy, Kasegaon, Sangli 415404, M.S., India
2 shared publications - Remeth Jacky Dias
Government college of pharmacy, Karad
2 shared publications - Akshay Ramchandra Yadav
Krishna College of Pharmacy, Karad, Maharashtra 415539, India
1 shared publication - Laxmikant M Purane
Faculty of Pharmacology, Yashoda Technical Campus, Wadhe, Satara 415 011, M.S., India
1 shared publication - Nilofar S. Naikwade
Professor & HOD Department of pharmacology, Appasaheb Birnale College of Pharmacy, Sangli, India
1 shared publication - Prakash Dilip Jadhav
Faculty of Pharmacology, Yashoda Technical Campus, Wadhe, Satara 415 011, M.S., India
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by Vita Scientia in Vita Scientia
- Vol. 2 (4) , 1-27
Neuroprotective Effects of Niranthin against Scopolamine-Induced Cognitive Impairment: Behavioral, Biochemical, and Molecular Docking Studies
Ethnopharmacological relevance: The ayurvedic and ethnobotanical literature indicates use of Phyllanthus to treat physical sensations, somatic signs of anxiety and CNS disorders. Niranthin, a lignan isolated from the aerial parts of the plant Phyllanthus amarus, exhibits a wide spectrum of pharmacological activities. Aim of the study: This investigation was intended to explore the anti-amnesic/ anti-Alzheimer potential of Niranthin and forecast possible role of similar class of compounds. Materials and methods: Niranthin was evaluated using established in vivo models, including the Morris Water Maze, Elevated Plus Maze, scopolamine-induced amnesia, and motor coordination tests. Its effect on cholinergic function was assessed through acetylcholinesterase inhibition. Molecular docking studies were performed to predict interactions with key Alzheimer’s disease targets, including acetylcholinesterase, butyrylcholinesterase, beta-secretase, tau protein kinase, and monoamine oxidases. Results: Niranthin significantly improved learning and memory in behavioral models and attenuated scopolamine-induced cognitive deficits. It demonstrated acetylcholinesterase inhibitory activity and showed potential involvement of the GABAergic system. Docking studies revealed strong binding affinity toward multiple targets associated with Alzheimer’s pathology. Additionally, Niranthin exhibited favorable physicochemical properties and predicted blood–brain barrier permeability Conclusion: The findings of present study suggest that Niranthin possesses promising multi-target neuroprotective properties against scopolamine-induced cognitive impairment. However, additional investigations including pharmacokinetic evaluation, chronic toxicity assessment, and validation in transgenic Alzheimer's disease models are required before therapeutic translation can be considered.
- 12 October 2026
- Published by Vita Scientia in Vita Scientia
- Vol. 2 (4) , 1-27
Open AccessNeuroprotective Effects of Niranthin against Scopolamine-Induced Cognitive Impairment: Behavioral, Biochemical, and Molecular Docking Studies
Ethnopharmacological relevance: The ayurvedic and ethnobotanical literature indicates use of Phyllanthus to treat physical sensations, somatic signs of anxiety and CNS disorders. Niranthin, a lignan isolated from the aerial parts of the plant Phyllanthus amarus, exhibits a wide spectrum of pharmacological activities. Aim of the study: This investigation was intended to explore the anti-amnesic/ anti-Alzheimer potential of Niranthin and forecast possible role of similar class of compounds. Materials and methods: Niranthin was evaluated using established in vivo models, including the Morris Water Maze, Elevated Plus Maze, scopolamine-induced amnesia, and motor coordination tests. Its effect on cholinergic function was assessed through acetylcholinesterase inhibition. Molecular docking studies were performed to predict interactions with key Alzheimer’s disease targets, including acetylcholinesterase, butyrylcholinesterase, beta-secretase, tau protein kinase, and monoamine oxidases. Results: Niranthin significantly improved learning and memory in behavioral models and attenuated scopolamine-induced cognitive deficits. It demonstrated acetylcholinesterase inhibitory activity and showed potential involvement of the GABAergic system. Docking studies revealed strong binding affinity toward multiple targets associated with Alzheimer’s pathology. Additionally, Niranthin exhibited favorable physicochemical properties and predicted blood–brain barrier permeability Conclusion: The findings of present study suggest that Niranthin possesses promising multi-target neuroprotective properties against scopolamine-induced cognitive impairment. However, additional investigations including pharmacokinetic evaluation, chronic toxicity assessment, and validation in transgenic Alzheimer's disease models are required before therapeutic translation can be considered.
- 1 March 2021
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 24 (3) , 415-422
An Insight Into the Anxiolytic Effects of Lignans (Phyllanthin and Hypophyllanthin) and Tannin (Corilagin) Rich Extracts of Phyllanthus amarus : An In-Silico and In-vivo approaches
: The extracts and the compounds isolated from Phyllanthus amarus Schumm and Thonn (Family: Euphorbiaceae) have shown a wide spectrum of pharmacological activities including antiviral, antibacterial, antiplasmodial, antimalarial, antimicrobial, anticancer, antidiabetic, hypolipidemic, antioxidant, hepatoprotective, nephroprotective and diurectic properties. Background: This investigation was aimed at exploring the anxiolytic potential of Phyllanthus amarus standardized extracts and predict probable role of marker phyto constitutents. Objective and Methods: Three standardized extracts of Phyllanthus amarus plant viz. standardized aqueous extract of Phyllanthus amarus whole plant (PAAE), standardized methanolic extract of P. amarus leaf (PAME) and the standardized hydro-methanolic extract of P. amarus leaf (PAHME) were tested in the classical animal models of anxiety: Elevated plus-maze model and Light & Dark Exploration test. Results: The lower doses of the tannin rich extract (PAHME) of the P. amarus possess significant anxiolytic activity compared to lignin rich (PAME) and aqueous extracts (PAAE), while at a higher dose (400mg/kg) the results of all three extracts appears to be potentially sedative. While the molecular docking studies support these probable anxiolytic, the sedative effects of the Phyllanthus amarus extracts could be due to the interaction of tannins and lignans with the GABAbenzodiazepine receptor complex. Conclusion: The results of the present study indicate that the tannin-rich extract of the P. amarus may have potential clinical applications in the management of anxiety. It can be further studied for optimum dosage to be used as a future of anti-anxiety drug development or as a standardized Phytomedicine.
- 1 March 2021
- Published by Bentham Science Publishers Ltd. in Combinatorial Chemistry & High Throughput Screening
- Vol. 24 (3) , 415-422
An Insight Into the Anxiolytic Effects of Lignans (Phyllanthin and Hypophyllanthin) and Tannin (Corilagin) Rich Extracts of Phyllanthus amarus : An In-Silico and In-vivo approaches
: The extracts and the compounds isolated from Phyllanthus amarus Schumm and Thonn (Family: Euphorbiaceae) have shown a wide spectrum of pharmacological activities including antiviral, antibacterial, antiplasmodial, antimalarial, antimicrobial, anticancer, antidiabetic, hypolipidemic, antioxidant, hepatoprotective, nephroprotective and diurectic properties. Background: This investigation was aimed at exploring the anxiolytic potential of Phyllanthus amarus standardized extracts and predict probable role of marker phyto constitutents. Objective and Methods: Three standardized extracts of Phyllanthus amarus plant viz. standardized aqueous extract of Phyllanthus amarus whole plant (PAAE), standardized methanolic extract of P. amarus leaf (PAME) and the standardized hydro-methanolic extract of P. amarus leaf (PAHME) were tested in the classical animal models of anxiety: Elevated plus-maze model and Light & Dark Exploration test. Results: The lower doses of the tannin rich extract (PAHME) of the P. amarus possess significant anxiolytic activity compared to lignin rich (PAME) and aqueous extracts (PAAE), while at a higher dose (400mg/kg) the results of all three extracts appears to be potentially sedative. While the molecular docking studies support these probable anxiolytic, the sedative effects of the Phyllanthus amarus extracts could be due to the interaction of tannins and lignans with the GABAbenzodiazepine receptor complex. Conclusion: The results of the present study indicate that the tannin-rich extract of the P. amarus may have potential clinical applications in the management of anxiety. It can be further studied for optimum dosage to be used as a future of anti-anxiety drug development or as a standardized Phytomedicine.